Showing 90 Result(s)

Oladoctor Launches in Spain, Portugal, France, and Germany, Connecting Patients with Licensed Doctors Online

Valencia, Spain, November 21, 2024 –Oladoctor, a new digital health platform, now connects patients across Spain, Portugal, France, and Germany with licensed doctors for fast, convenient access to online consultations, prescription refills, and health referrals – all from the comfort of their home. Designed for individuals who prefer consultations in their native language, Oladoctor is …

From Diagnosis to Empowerment: Navigating the Epilepsy Journey

By – Dr. Ravi Kumar CP, Consultant – Pediatric Neurology, Aster CMI Hospital, Bangalore Epilepsy is one of the most common neurological disorders affecting approximately 1 in 100 people in India. Characterized by recurrent seizures, which result from abnormal electrical activity in the brain. Seizures can vary in type and severity, and their unpredictability can …

AIIMS, Bathinda & Swasti, The Health Catalyst Jointly Launched an Advisory to Mitigate Harsh Winters

November 11, 2024,India : The Department of Community & Family Medicine, All India Institute of Medical Sciences (AIIMS), Bathinda (Punjab) in collaboration with Swasti, The Health Catalyst, has jointly launched an advisory to help communities prepare for the upcoming winter and cold waves. According to India Meteorological Department (IMD) following an intense summer, India may …

GlycoMira Therapeutics Advances Cancer Care with Patent for First-in-Class Therapy

Salt Lake City, UT, November 04, 2024 — GlycoMira Therapeutics announced that the US Patent Office has issued a key patent, US Patent No. 12109225, covering the Company’s novel first-in-class anti-tumor therapeutic. In pre-clinical studies, GlycoMira’s lead compound, GM-1111, has been shown to significantly improve the effectiveness of radiation in reducing tumor volume, along with …

Neutrogena Unveils Game-Changing Collaboration with Top Dermatology Experts

November 04, 2024,Skillman, N.J., United States : Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establishing multi-year partnerships with Dr. Dhaval Bhanusali, renowned skincare innovator, and Dr. Muneeb Shah, the most followed dermatologist worldwide2. This …

Revolutionizing Study Design: Medidata Introduces New Solutions for Oncology and Vaccine Research

November 04, 2024,New York, United States : Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has introduced two new bundled offerings to meet the growing demands of oncology and vaccine research. Medidata Oncology Solutions and Medidata Vaccine Solutions reinforce the FDA guidance for patient-centered endpoints, adaptive …